Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG). (Q33332083)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG). |
scientific article |
Statements
1 reference
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG). (English)
1 reference
C Sessa
1 reference
J Wanders
1 reference
M Roelvink
1 reference
P Dombernowsky
1 reference
D Nielsen
1 reference
R Morant
1 reference
P Drings
1 reference
P Wissel
1 reference
A R Hanauske
1 reference
1 February 2000
1 reference
1 reference
Identifiers
1 reference